In this article
WeightCare’s semaglutide page offers month-to-month care alongside longer packages and financing. The monthly figure shown for a package does not necessarily describe a subscription that can be stopped after one payment.
The page also contains differing statements about starter eligibility and service areas. This guide compares the published payment structures while treating those unresolved eligibility details as questions for the provider.
Separate a monthly subscription, a prepaid treatment package, and financing installments before comparing affordability. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.
What to know first
- Separate a monthly subscription, a prepaid treatment package, and financing installments before comparing affordability.
- CoreAge Rx is the first listing through a disclosed commercial arrangement.
- Confirm the proposed product, care arrangement, and complete written payment terms.
How this shortlist was selected
CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.
Separate a monthly subscription, a prepaid treatment package, and financing installments before comparing affordability. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.
01. CoreAge Rx — featured partner
Our featured commercial comparison for a self-pay medication plan. Ask for the entire selected-term payment and any financing conditions rather than comparing monthly equivalents alone.
The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.
The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.
Continue with our CoreAge Rx review and pricing details.
02. Brightmeds
Publishes a single-month price and a separate three-month campaign charge. These make a useful comparison with WeightCare’s two shorter payment choices.
The Brightmeds Summer Special page lists semaglutide at $297 for three months ($99 per month), or $129 for a single month. Tirzepatide is $357 for three months ($119 per month), or $149 for a single month. These are dated campaign offers.
Confirm whether the campaign remains available for your prescription and what the renewal costs. The three-month equivalent is not the charge for the separately listed single-month option.
Check the official Brightmeds program page for the current offer and conditions. Our Brightmeds alternatives comparison examines other care models.
03. Yucca Health
Offers published monthly and six-month options. Compare full commitments and follow-up arrangements over the same period.
Yucca lists semaglutide at $125 per month on a six-month plan totaling $750, or $146 month to month. Tirzepatide is listed at $225 per month on a six-month plan totaling $1,350, or $258 month to month.
The $125 headline is a prepaid-plan equivalent, not the monthly-plan charge. Keep the selected term, renewal price, and cancellation policy with the purchase summary.
Check the official Yucca Health program page for the current offer and conditions. Our Yucca Health alternatives comparison examines other care models.
04. GobyMeds
A starter-bundle comparison with explicit three-month totals. Confirm transfer eligibility and renewal pricing before treating it as a replacement for ongoing care.
GobyMeds lists a three-month semaglutide starter bundle at $299 total and a tirzepatide starter bundle at $399 total. Its $99 and $133 monthly headlines describe those bundles; the page says the lowest figures can reflect multi-month or introductory offers.
Cancellation depends on whether the prescription has reached the pharmacy. A prepaid starter bundle is not a guarantee of the same renewal price, and HSA/FSA payment is not insurance coverage.
Check the official GobyMeds program page for the current offer and conditions.
05. Fifty 410
Lists a monthly semaglutide option and separate tirzepatide package tiers. Keep the medicine and prescribed period consistent with the WeightCare quote.
Fifty 410 lists a three-month compounded tirzepatide starter package at $399 total, displayed as $133 per month. The listed mid- and higher-dose packages are $499 and $549 total. Its semaglutide monthly option is $199. These are different products and package sizes.
Ask which package matches the proposed prescription and whether a returning patient qualifies for a starter offer. A three-month supply and monthly billing are separate arrangements.
Check the official Fifty 410 program page for the current offer and conditions. Our Fifty 410 alternatives comparison examines other care models.
06. Mochi Health
A recurring membership-plus-medication model that may provide a different payment cadence. Add both components and check the selected term.
Mochi advertises a $39 first membership month for eligible new subscribers and a $79 ongoing monthly membership. Its August 2026 pricing explanation describes dose-based compounded semaglutide prices of $60–$99 and tirzepatide prices of $90–$199, with medication billed separately.
Mochi’s pricing article says its transition to dose-based prices did not change the pharmacies or additives for the plans discussed. It does not identify your personal dispensing pharmacy. Confirm the pharmacy and complete formulation shown in your own care plan.
Continue with our Mochi Health review and pricing details.
The current WeightCare baseline
WeightCare’s semaglutide page lists $399 month to month and $747 paid at the start for three months ($249 per month). It also displays lower monthly equivalents for six- and 12-month plans, which should be quoted as full commitments.
The program describes a telehealth visit, medication if prescribed, clinician messaging, monthly check-ins, and access to lifestyle resources.
The page contains different statements about starter eligibility and state availability. Confirm both for your selected plan. Financing installments do not turn a prepaid package into a cancellable monthly subscription.
The details that decide this comparison
Compare the listed $399 month-to-month option separately from the $747 three-month upfront package. Longer offers need their own total and payment schedule.
Ask whether your prescribed treatment and location qualify for the selected package. Conflicting page sections should be resolved in writing before purchase.
If financing is offered, read the repayment agreement and ask how cancellation or a clinical change affects it. Stopping treatment does not automatically cancel a financing obligation.
Keep the treatment distinction clear
An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.
Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.
Before you make a change
Request the clinical cancellation policy and any financing agreement as separate documents. Each governs a different part of the transaction.
If you prefer a shorter commitment while discussing tolerability with a clinician, compare the actual monthly options first. A larger discount is not the only useful financial criterion.
Sources & research notes
Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.
- CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
- CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
- CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
- CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
- CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
- Brightmeds: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Yucca Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- GobyMeds: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Fifty 410: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Online Medical Weight Loss Program | Mochi HealthProvider-published information · Checked September 21, 2026
- Mochi: August 2026 dose-based pricingProvider-published information · Checked September 21, 2026
- Contact us | Mochi HealthProvider-published information · Checked September 21, 2026
- WeightCare: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
- FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026
Read our methodology · Commercial disclosure · Request a correction